IVV vs WDNA
iShares Core S&P 500 ETF vs Wisdomtree BioRevolution Fund
Which is better, IVV or WDNA?
Large Cap Blend against Mid Cap Growth.
IVV has a lower expense ratio. IVV led over 3Y, 5Y and the full window, WDNA over 1Y. WDNA is less concentrated, with 32.4% of the fund in its ten largest positions against 37.9%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | IVV | WDNA |
|---|---|---|
| Expense Ratio | 0.03%Best | 0.45% |
| AUM | $876.4B | $3M |
| Dividend Yield | 1.06% | 3.34% |
| Holdings | 508 | 87 |
| YTD Return | +11.57% | +30.67%Best |
| 1Y Return | +17.57% | +53.35%Best |
| 3Y Return (annualized) | +20.71%Best | +11.27% |
| 5Y Return (annualized) | +12.80%Best | -3.53% |
| Volatility (annualized) | 15.6%Best | 24.0% |
| Max Drawdown | -24.5%Best | -58.9% |
| $10,000 over 5 years | $18,262Best | $8,355 |
| Top 10 Weight | 37.9% | 32.4%Best |
| Fund Family | iShares by BlackRock (US) | WisdomTree Investments |
| Category | Equity | Equity |
| Style | Large Cap Blend | Mid Cap Growth |
| Inception | May 15, 2000 | Jun 3, 2021 |
Volatility and max drawdown are measured over the window both funds cover: Jun 3, 2021 to Sep 10, 2026 (5.3 years).
IVV vs WDNA growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 5.3 years both funds cover.
IVV vs WDNA Performance
iShares Core S&P 500 ETF (IVV) is an ETF from iShares by BlackRock (US) and Wisdomtree BioRevolution Fund (WDNA) is an ETF from WisdomTree Investments. Over the past year IVV returned +17.57% while WDNA returned +53.35%. Year to date, IVV is up 11.57% versus a gain of 30.67% for WDNA.
Over three years, IVV compounded at +20.71% per year against +11.27% for WDNA; over five years the annualized figures are +12.80% and -3.53% respectively.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
WDNA has been the more volatile fund, with annualized monthly volatility of 24.0% compared with 15.6% for IVV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -24.5% for IVV and -58.9% for WDNA. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.65. They move together some of the time, and apart the rest.
Fees and Cost Over Time
IVV charges 0.03% per year while WDNA charges 0.45%. On a $10,000 position that is $3 vs $45 annually, a gap of $42 per year that compounds over a long holding period. On income, IVV currently yields 1.06% against 3.34% for WDNA.
Holdings Overlap
4.8% of IVV's money is in holdings WDNA also owns. 27.0% of WDNA's money is in holdings IVV also owns.
WDNA and IVV share little of their money.
18 positions in common, counted across the 505 positions we hold weights for in IVV and 79 in WDNA, against full books of 508 and 87.
What only one of them owns
Our book lists 44 positions for WDNA that do not appear in our book for IVV (54.0% of the fund), and 477 for IVV that do not appear in WDNA (94.5%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in IVV | Weight in WDNA | Difference |
|---|---|---|---|
| LLYEli Lilly & Co. | 1.39% | 4.10% | 2.71% |
| JNJJohnson & Johnson | 0.93% | 3.00% | 2.07% |
| MRNAModerna Inc | 0.03% | 3.48% | 3.45% |
| TMOThermo Fisher Scientific Inc | 0.32% | 1.78% | 1.46% |
| AMGNAmgen Inc. | 0.33% | 1.75% | 1.42% |
| CTVACorteva Inc. | 0.08% | 1.76% | 1.68% |
| GILDGilead Sciences Inc | 0.25% | 1.56% | 1.31% |
| PFEPfizer, Inc. | 0.22% | 1.48% | 1.26% |
| BGBunge Global Sa Common Shares | 0.02% | 1.56% | 1.54% |
| VRTXVertex Pharmaceuticals Inc | 0.18% | 1.39% | 1.21% |
27.0% of WDNA is already inside IVV.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, IVV or WDNA?
IVV has an expense ratio of 0.03% while WDNA charges 0.45%. IVV is the cheaper option, by $42 a year on a $10,000 investment.
Which performed better, IVV or WDNA?
Over the past year IVV returned +17.57% vs +53.35% for WDNA, so WDNA leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, IVV or WDNA?
WDNA has been the more volatile fund at 24.0% annualized versus 15.6% for IVV. Worst drawdown: IVV -24.5% vs WDNA -58.9%.
Should I hold both IVV and WDNA?
IVV and WDNA have a monthly-return correlation of 0.65, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between IVV and WDNA?
27.0% of WDNA's money is in holdings IVV also owns. 27.0% of WDNA's is in holdings IVV also owns. They hold 18 positions in common, counted across the 505 positions we hold weights for in IVV and 79 in WDNA.
Which pays a higher dividend, IVV or WDNA?
IVV yields 1.06% while WDNA yields 3.34%, so WDNA currently pays the higher dividend yield.
Is WDNA better than IVV?
IVV has a lower expense ratio. IVV led over 3Y, 5Y and the full window, WDNA over 1Y. WDNA is less concentrated, with 32.4% of the fund in its ten largest positions against 37.9%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.